Yield10 Bioscience Q3 2023 EPS $(0.41) Misses $(0.39) Estimate
Portfolio Pulse from vinayak@benzinga.com
Yield10 Bioscience (NASDAQ:YTEN) reported a Q3 2023 EPS loss of $(0.41), missing the consensus estimate of $(0.39) by 5.13%. However, this represents a 42.25% improvement from the $(0.71) per share loss in the same quarter last year.
November 14, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Yield10 Bioscience reported a larger-than-expected loss per share in Q3 2023, missing estimates by 5.13%, but improved from the previous year's loss.
Missing the EPS estimate is likely to negatively impact investor sentiment in the short term, leading to a potential decrease in stock price. However, the improvement from the previous year's loss may mitigate some negative sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100